Morgan Stanley’s Bio-Rad Laboratories Class B BIO.B Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $170K | Hold |
712
| – | – | ﹤0.01% | 5914 |
|
|
2025
Q1 | $172K | Hold |
712
| – | – | ﹤0.01% | 5793 |
|
|
2024
Q4 | $230K | Hold |
712
| – | – | ﹤0.01% | 5734 |
|
|
2024
Q3 | $235K | Hold |
712
| – | – | ﹤0.01% | 5692 |
|
|
2024
Q2 | $190K | Sell |
712
-12
| -2% | -$3.2K | ﹤0.01% | 5706 |
|
|
2024
Q1 | $247K | Sell |
724
-724
| -50% | -$247K | ﹤0.01% | 5652 |
|
|
2023
Q4 | $461K | Buy |
1,448
+724
| +100% | +$230K | ﹤0.01% | 5646 |
|
|
2023
Q3 | $257K | Hold |
724
| – | – | ﹤0.01% | 5469 |
|
|
2023
Q2 | $272K | Hold |
724
| – | – | ﹤0.01% | 5507 |
|
|
2023
Q1 | $343K | Hold |
724
| – | – | ﹤0.01% | 5460 |
|
|
2022
Q4 | $298K | Hold |
724
| – | – | ﹤0.01% | 5495 |
|
|
2022
Q3 | $302K | Hold |
724
| – | – | ﹤0.01% | 5521 |
|
|
2022
Q2 | $358K | Buy |
724
+32
| +5% | +$15.8K | ﹤0.01% | 5589 |
|
|
2022
Q1 | $389K | Hold |
692
| – | – | ﹤0.01% | 5557 |
|
|
2021
Q4 | $522K | Hold |
692
| – | – | ﹤0.01% | 5519 |
|
|
2021
Q3 | $514K | Hold |
692
| – | – | ﹤0.01% | 5477 |
|
|
2021
Q2 | $443K | Hold |
692
| – | – | ﹤0.01% | 5602 |
|
|
2021
Q1 | $394K | Hold |
692
| – | – | ﹤0.01% | 5288 |
|
|
2020
Q4 | $403K | Hold |
692
| – | – | ﹤0.01% | 5218 |
|
|
2020
Q3 | $353K | Sell |
692
-10
| -1% | -$5.1K | ﹤0.01% | 4811 |
|
|
2020
Q2 | $317K | Buy |
702
+180
| +34% | +$81.3K | ﹤0.01% | 4840 |
|
|
2020
Q1 | $182K | Hold |
522
| – | – | ﹤0.01% | 4903 |
|
|
2019
Q4 | $193K | Hold |
522
| – | – | ﹤0.01% | 5425 |
|
|
2019
Q3 | $173K | Hold |
522
| – | – | ﹤0.01% | 5205 |
|
|
2019
Q2 | $163K | Buy |
+522
| New | +$163K | ﹤0.01% | 5113 |
|
|
2019
Q1 | – | Sell |
-550
| Closed | -$127K | – | 6592 |
|
|
2018
Q4 | $127K | Sell |
550
-250
| -31% | -$57.7K | ﹤0.01% | 5455 |
|
|
2018
Q3 | $250K | Buy |
+800
| New | +$250K | ﹤0.01% | 5347 |
|